Regulating Fbw7 on the road to cancer

Seminars in Cancer Biology

Volumn 36, Issue , 2016, Pages 62-70

  Xu, Wenshan ^a   Taranets, Lyudmyla ^a   Popov, Nikita ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Fbw7; Oncogene; Protein degradation; SCF ubiquitin ligase; Tumor suppressor

Indexed keywords

CARCINOGENESIS; ANIMAL; CELL TRANSFORMATION; CHEMISTRY; ENZYME SPECIFICITY; GENE EXPRESSION REGULATION; GENETICS; HOMEOSTASIS; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOPLASMS; PATHOLOGY; PROTEIN DEGRADATION; PROTEIN MULTIMERIZATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; UBIQUITINATION;

CELL CYCLE PROTEIN; F BOX PROTEIN; FBXW7 PROTEIN, HUMAN; PROTEIN BINDING; UBIQUITIN PROTEIN LIGASE;

ANIMALS; CELL CYCLE PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; F-BOX PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEOSTASIS; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN TRANSPORT; PROTEOLYSIS; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84958159750     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2015.09.005     Document Type: Review

References (111)

1. Cardozo T., Pagano M. The SCF ubiquitin ligase: insights into a molecular machine. Nat. Rev. Mol. Cell Biol. 2004, 5:739-751. 10.1038/nrm1471.
2. Lydeard J.R., Schulman B.A., Harper J.W. Building and remodelling Cullin-RING E3 ubiquitin ligases. EMBO Rep. 2013, 14:1050-1061. 10.1038/embor.2013.173.
3. Skaar J.R., Pagan J.K., Pagano M. Mechanisms and function of substrate recruitment by F-box proteins. Nat. Rev. Mol. Cell Biol. 2013, 14:369-381. 10.1038/nrm3582.
4. Wei D., Sun Y. Small RING finger proteins RBX1 and RBX2 of SCF E3 ubiquitin ligases: the role in cancer and as cancer targets. Genes Cancer 2010, 1:700-707. 10.1177/1947601910382776.
5. Welcker M., Orian A., Grim J.E., Grim J.A., Eisenman R.N., Clurman B.E. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size. Curr. Biol. 2004, 14:1852-1857. 10.1016/j.cub.2004.09.083.
6. Zhang W., Koepp D.M. Fbw7 isoform interaction contributes to cyclin E proteolysis. Mol. Cancer Res. 2006, 4:935-943. 10.1158/1541-7786.MCR-06-0253.
7. Welcker M., Clurman B.E. Fbw7/hCDC4 dimerization regulates its substrate interactions. Cell Div. 2007, 2:7. 10.1186/1747-1028-2-7.
8. Hao B., Oehlmann S., Sowa M.E., Harper J.W., Pavletich N.P. Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases. Mol. Cell 2007, 26:131-143. 10.1016/j.molcel.2007.02.022.
9. Tang X., Orlicky S., Lin Z., Willems A., Neculai D., Ceccarelli D., et al. Suprafacial orientation of the SCFCdc4 dimer accommodates multiple geometries for substrate ubiquitination. Cell 2007, 129:1165-1176. 10.1016/j.cell.2007.04.042.
10. Akhoondi S., Sun D., von der Lehr N., Apostolidou S., Klotz K., Maljukova A., et al. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res. 2007, 67:9006-9012. 10.1158/0008-5472.CAN-07-1320.
11. Welcker M., Clurman B.E. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat. Rev. Cancer 2008, 8:83-93. 10.1038/nrc2290.
12. Welcker M., Larimore E.A., Swanger J., Bengoechea-Alonso M.T., Grim J.E., Ericsson J., et al. Fbw7 dimerization determines the specificity and robustness of substrate degradation. Genes Dev. 2013, 27:2531-2536. 10.1101/gad.229195.113.
13. Rajagopalan H., Jallepalli P.V., Rago C., Velculescu V.E., Kinzler K.W., Vogelstein B., et al. Inactivation of hCDC4 can cause chromosomal instability. Nature 2004, 428:77-81. 10.1038/nature02313.
14. Welcker M., Orian A., Jin J., Grim J.E., Grim J.A., Harper J.W., et al. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:9085-9090. 10.1073/pnas.0402770101.
15. Yada M., Hatakeyama S., Kamura T., Nishiyama M., Tsunematsu R., Imaki H., et al. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J. 2004, 23:2116-2125. 10.1038/sj.emboj.7600217.
16. Nateri A.S., Riera-Sans L., Da Costa C., Behrens A. The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling. Science 2004, 303:1374-1378. 10.1126/science.1092880.
17. Inuzuka H., Shaik S., Onoyama I., Gao D., Tseng A., Maser R.S., et al. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature 2011, 471:104-109. 10.1038/nature09732.
18. Wertz I.E., Kusam S., Lam C., Okamoto T., Sandoval W., Anderson D.J., et al. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature 2011, 471:110-114. 10.1038/nature09779.
19. Thompson B.J., Buonamici S., Sulis M.L., Palomero T., Vilimas T., Basso G., et al. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J. Exp. Med. 2007, 204:1825-1835. 10.1084/jem.20070872.
20. Matsuoka S., Oike Y., Onoyama I., Iwama A., Arai F., Takubo K., et al. Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL. Genes Dev. 2008, 22:986-991. 10.1101/gad.1621808.
21. Ishikawa Y., Hosogane M., Okuyama R., Aoyama S., Onoyama I., Nakayama K.I., et al. Opposing functions of Fbxw7 in keratinocyte growth, differentiation and skin tumorigenesis mediated through negative regulation of c-Myc and Notch. Oncogene 2013, 32:1921-1932. 10.1038/onc.2012.213.
22. Hoeck J.D., Jandke A., Blake S.M., Nye E., Spencer-Dene B., Brandner S., et al. Fbw7 controls neural stem cell differentiation and progenitor apoptosis via Notch and c-Jun. Nat. Neurosci. 2010, 13:1365-1372. 10.1038/nn.2644.
23. Matsumoto A., Onoyama I., Sunabori T., Kageyama R., Okano H., Nakayama K.I. Fbxw7-dependent degradation of Notch is required for control of "stemness" and neuronal-glial differentiation in neural stem cells. J. Biol. Chem. 2011, 286:13754-13764. 10.1074/jbc.M110.194936.
24. Onoyama I., Suzuki A., Matsumoto A., Tomita K., Katagiri H., Oike Y., et al. Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver. J. Clin. Investig. 2011, 121:342-354. 10.1172/JCI40725.
25. Sancho R., Gruber R., Gu G., Behrens A. Loss of Fbw7 reprograms adult pancreatic ductal cells into α, δ, and β cells. Cell Stem Cell 2014, 15:139-153. 10.1016/j.stem.2014.06.019.
26. Kourtis N., Moubarak R.S., Aranda-Orgilles B., Lui K., Aydin I.T., Trimarchi T., et al. FBXW7 modulates cellular stress response and metastatic potential through HSF1 post-translational modification. Nat. Cell Biol. 2015, 17:322-332. 10.1038/ncb3121.
27. Matsumoto A., Tateishi Y., Onoyama I., Okita Y., Nakayama K., Nakayama K.I. Fbxw7β resides in the endoplasmic reticulum membrane and protects cells from oxidative stress. Cancer Sci. 2011, 102:749-755. 10.1111/j.1349-7006.2011.01851.x.
28. Balamurugan K., Sharan S., Klarmann K.D., Zhang Y., Coppola V., Summers G.H., et al. FBXW7α attenuates inflammatory signalling by downregulating C/EBPδ and its target gene Tlr4. Nat. Commun. 2013, 4:1662. 10.1038/ncomms2677.
29. Flügel D., Görlach A., Kietzmann T. GSK-3β regulates cell growth, migration, and angiogenesis via Fbw7 and USP28-dependent degradation of HIF-1α. Blood 2012, 119:1292-1301. 10.1182/blood-2011-08-375014.
30. Wang L., Ye X., Liu Y., Wei W., Wang Z. Aberrant regulation of FBW7 in cancer. Oncotarget 2014, 5:2000-2015.
31. Punga T., Bengoechea-Alonso M.T., Ericsson J. Phosphorylation and ubiquitination of the transcription factor sterol regulatory element-binding protein-in response to DNA binding. J. Biol. Chem. 2006, 281:25278-25286. 10.1074/jbc.M604983200.
32. Grim J.E., Knoblaugh S.E., Guthrie K.A., Hagar A., Swanger J., Hespelt J., et al. Fbw7 and p53 cooperatively suppress advanced and chromosomally unstable intestinal cancer. Mol. Cell. Biol. 2012, 32:2160-2167. 10.1128/MCB.00305-12.
33. Wu R.-C., Feng Q., Lonard D.M., O'Malley B.W. SRC-coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock. Cell 2007, 129:1125-1140. 10.1016/j.cell.2007.04.039.
34. Geng F., Wenzel S., Tansey W.P. Ubiquitin and proteasomes in transcription. Annu. Rev. Biochem. 2012, 81:177-201. 10.1146/annurev-biochem-052110-120012.
35. Farrell A.S., Pelz C., Wang X., Daniel C.J., Wang Z., Su Y., et al. Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesis. Mol. Cell. Biol. 2013, 33:2930-2949. 10.1128/MCB.01455-12.
36. Davis M.A., Larimore E.A., Fissel B.M., Swanger J., Taatjes D.J., Clurman B.E. The SCF-Fbw7 ubiquitin ligase degrades MED13 and MED13L and regulates CDK8 module association with mediator. Genes Dev. 2013, 27:151-156. 10.1101/gad.207720.112.
37. Allen B.L., Taatjes D.J. The mediator complex: a central integrator of transcription. Nat. Rev. Mol. Cell Biol. 2015, 16:155-166. 10.1038/nrm3951.
38. Sancho R., Jandke A., Davis H., Diefenbacher M.E., Tomlinson I., Behrens A. F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor. Gastroenterology 2010, 139:929-941. 10.1053/j.gastro.2010.05.078.
39. King B., Trimarchi T., Reavie L., Xu L., Mullenders J., Ntziachristos P., et al. The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability. Cell 2013, 153:1552-1566. 10.1016/j.cell.2013.05.041.
40. Mao J.-H., Perez-losada J., Wu D., DelRosario R., Tsunematsu R., Nakayama K.I., et al. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene. Nature 2004, 432:775-779. 10.1038/nature03155.
41. Reavie L., Buckley S.M., Loizou E., Takeishi S., Aranda-Orgilles B., Ndiaye-Lobry D., et al. Regulation of c-Myc ubiquitination controls chronic myelogenous leukemia initiation and progression. Cancer Cell 2013, 23:362-375. 10.1016/j.ccr.2013.01.025.
42. Takeishi S., Matsumoto A., Onoyama I., Naka K., Hirao A., Nakayama K.I. Ablation of Fbxw7 eliminates leukemia-initiating cells by preventing quiescence. Cancer Cell 2013, 23:347-361. 10.1016/j.ccr.2013.01.026.
43. Rocher-Ros V., Marco S., Mao J.-H., Gines S., Metzger D., Chambon P., et al. Presenilin modulates EGFR signaling and cell transformation by regulating the ubiquitin ligase Fbw7. Oncogene 2010, 29:2950-2961. 10.1038/onc.2010.57.
44. Galli F., Rossi M., D'Alessandra Y., De Simone M., Lopardo T., Haupt Y., et al. MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation. J. Cell Sci. 2010, 123:2423-2433. 10.1242/jcs.061010.
45. Busino L., Millman S.E., Scotto L., Kyratsous C.A., Basrur V., O'Connor O., et al. Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma. Nat. Cell Biol. 2012, 14:375-385. 10.1038/ncb2463.
46. Cerami E., Gao J., Dogrusoz U., Gross B.E., Sumer S.O., Aksoy B.A., et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012, 2:401-404. 10.1158/2159-8290.CD-12-0095.
47. Mao J.-H., Kim I.-J., Wu D., Climent J., Kang H.C., DelRosario R., et al. FBXW7 targets mTOR for Degradation and genetically cooperates with PTEN in tumor suppression. Science 2008, 321:1499-1502. 10.1126/science.1162981.
48. Akhoondi S., Lindström L., Widschwendter M., Corcoran M., Bergh J., Spruck C., et al. Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer. Breast Cancer Res. 2010, 12:R105. 10.1186/bcr2788.
49. Davis R.J., Welcker M., Clurman B.E. Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities. Cancer Cell 2014, 26:455-464. 10.1016/j.ccell.2014.09.013.
50. Davis H., Lewis A., Behrens A., Tomlinson I. Investigation of the atypical FBXW7 mutation spectrum in human tumours by conditional expression of a heterozygous propellor tip missense allele in the mouse intestines. Gut 2014, 63:792-799. 10.1136/gutjnl-2013-304719.
51. Davis H., Lewis A., Spencer-Dene B., Tateossian H., Stamp G., Behrens A., et al. FBXW7 mutations typically found in human cancers are distinct from null alleles and disrupt lung development. J. Pathol. 2011, 224:180-189. 10.1002/path.2874.
52. Welcker M., Singer J., Loeb K.R., Grim J., Bloecher A., Gurien-West M., et al. Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol. Cell 2003, 12:381-392.
53. Olson B.L., Hock M.B., Ekholm-Reed S., Wohlschlegel J.A., Dev K.K., Kralli A., et al. SCFCdc4 acts antagonistically to the PGC-1α transcriptional coactivator by targeting it for ubiquitin-mediated proteolysis. Genes Dev. 2008, 22:252-264. 10.1101/gad.1624208.
54. Taira N., Mimoto R., Kurata M., Yamaguchi T., Kitagawa M., Miki Y., et al. DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells. J. Clin. Investig. 2012, 122:859-872. 10.1172/JCI60818.
55. Yeh E.S., Lew B.O., Means A.R. The loss of PIN1 deregulates cyclin E and sensitizes mouse embryo fibroblasts to genomic instability. J. Biol. Chem. 2006, 281:241-251. 10.1074/jbc.M505770200.
56. Yeh E., Cunningham M., Arnold H., Chasse D., Monteith T., Ivaldi G., et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat. Cell Biol. 2004, 6:308-318. 10.1038/ncb1110.
57. Matsumoto A., Onoyama I., Nakayama K.I. Expression of mouse Fbxw7 isoforms is regulated in a cell cycle- or p53-dependent manner. Biochem. Biophys. Res. Commun. 2006, 350:114-119. 10.1016/j.bbrc.2006.09.003.
58. Sionov R.V., Netzer E., Shaulian E. Differential regulation of FBXW7 isoforms by various stress stimuli. Cell Cycle 2013, 12:3547-3554. 10.4161/cc.26591.
59. Yumimoto K., Akiyoshi S., Ueo H., Sagara Y., Onoyama I., Ueo H., et al. F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner. J. Clin. Investig. 2015, 125:621-635. 10.1172/JCI78782.
60. Kimura T., Gotoh M., Nakamura Y., Arakawa H. hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53. Cancer Sci. 2003, 94:431-436.
61. Grinkevich V.V., Nikulenkov F., Shi Y., Enge M., Bao W., Maljukova A., et al. Ablation of key oncogenic pathways by RITA-reactivated p53 is required for efficient apoptosis. Cancer Cell 2009, 15:441-453. 10.1016/j.ccr.2009.03.021.
62. Sancho R., Blake S.M., Tendeng C., Clurman B.E., Lewis J., Behrens A. Fbw7 repression by Hes5 creates a feedback loop that modulates Notch-mediated intestinal and neural stem cell fate decisions. PLOS Biol. 2013, 11:e1001586. 10.1371/journal.pbio.1001586.
63. Mansour M.R., Sanda T., Lawton L.N., Li X., Kreslavsky T., Novina C.D., et al. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia. J. Exp. Med. 2013, 210:1545-1557. 10.1084/jem.20122516.
64. Kumar V., Palermo R., Talora C., Campese A.F., Checquolo S., Bellavia D., et al. Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia. Leukemia 2014, 28:2324-2335.
65. Wang Q., Li D.-C., Li Z.-F., Liu C.-X., Xiao Y.-M., Zhang B., et al. Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen. Oncogene 2011, 30:3875-3886. 10.1038/onc.2011.103.
66. Lerner M., Lundgren J., Akhoondi S., Jahn A., Ng H.-F., Akbari Moqadam F., et al. MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression. Cell Cycle 2011, 10:2172-2183.
67. Olive V., Sabio E., Bennett M.J., De Jong C.S., Biton A., McGann J.C., et al. A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis. Elife 2013, 2:e00822. 10.7554/eLife.00822.
68. Zhou C., Shen L., Mao L., Wang B., Li Y., Yu H. miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7. Biochem. Biophys. Res. Commun. 2015, 458:63-69. 10.1016/j.bbrc.2015.01.066.
69. Jeon T.-I., Esquejo R.M., Roqueta-Rivera M., Phelan P.E., Moon Y.-A., Govindarajan S.S., et al. An SREBP-responsive microRNA operon contributes to a regulatory loop for intracellular lipid homeostasis. Cell Metab. 2013, 18:51-61. 10.1016/j.cmet.2013.06.010.
70. Gong J., Cui Z., Li L., Ma Q., Wang Q., Gao Y., et al. MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7. Tumour Biol. 2015, 10.1007/s13277-015-3510-3.
71. Li L., Sarver A.L., Khatri R., Hajeri P.B., Kamenev I., French A.J., et al. Sequential expression of miR-182 and miR-503 cooperatively targets FBXW7, contributing to the malignant transformation of colon adenoma to adenocarcinoma. J. Pathol. 2014, 234:488-501. 10.1002/path.4407.
72. Durgan J., Parker P.J. Regulation of the tumour suppressor Fbw7α by PKC-dependent phosphorylation and cancer-associated mutations. Biochem. J. 2010, 432:77-87. 10.1042/BJ20100799.
73. Grim J.E., Gustafson M.P., Hirata R.K., Hagar A.C., Swanger J., Welcker M., et al. Isoform- and cell cycle-dependent substrate degradation by the Fbw7 ubiquitin ligase. J. Cell Biol. 2008, 181:913-920. 10.1083/jcb.200802076.
74. Van Drogen F., Sangfelt O., Malyukova A., Matskova L., Yeh E., Means A.R., et al. Ubiquitylation of cyclin E requires the sequential function of SCF complexes containing distinct hCdc4 isoforms. Mol. Cell 2006, 23:37-48. 10.1016/j.molcel.2006.05.020.
75. Trausch-Azar J.S., Abed M., Orian A., Schwartz A.L. Isoform-specific SCF(Fbw7) ubiquitination mediates differential regulation of PGC-1α. J. Cell. Physiol. 2015, 230:842-852. 10.1002/jcp.24812.
76. Ekholm-Reed S., Goldberg M.S., Schlossmacher M.G., Reed S.I. Parkin-dependent degradation of the F-Box protein Fbw7β promotes neuronal survival in response to oxidative stress by stabilizing Mcl-1. Mol. Cell. Biol. 2013, 33:3627-3643. 10.1128/MCB.00535-13.
77. Bonetti P., Davoli T., Sironi C., Amati B., Pelicci P.G., Colombo E. Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7 gamma. J. Cell Biol. 2008, 182:19-26. 10.1083/jcb.200711040.
78. Welcker M., Larimore E.A., Frappier L., Clurman B.E. Nucleolar targeting of the Fbw7 ubiquitin ligase by a pseudosubstrate and glycogen synthase kinase 3. Mol. Cell. Biol. 2011, 31:1214-1224. 10.1128/MCB.01347-10.
79. Welcker M., Clurman B.E. The SV40 large T antigen contains a decoy phosphodegron that mediates its interactions with Fbw7/hCdc4. J. Biol. Chem. 2005, 280:7654-7658. 10.1074/jbc.M413377200.
80. Min S.-H., Lau A.W., Lee T.H., Inuzuka H., Wei S., Huang P., et al. Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase. Mol. Cell 2012, 46:771-783. 10.1016/j.molcel.2012.04.012.
81. Galan J.M., Peter M. Ubiquitin-dependent degradation of multiple F-box proteins by an autocatalytic mechanism. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:9124-9129.
82. Schülein C., Eilers M., Popov N. PI3K-dependent phosphorylation of Fbw7 modulates substrate degradation and activity. FEBS Lett. 2011, 585:2151-2157. 10.1016/j.febslet.2011.05.036.
83. Mo J.-S., Ann E.-J., Yoon J.-H., Jung J., Choi Y.-H., Kim H.-Y., et al. Serum- and glucocorticoid-inducible kinase 1 (SGK1) controls Notch1 signaling by downregulation of protein stability through Fbw7 ubiquitin ligase. J. Cell Sci. 2011, 124:100-112. 10.1242/jcs.073924.
84. Cizmecioglu O., Krause A., Bahtz R., Ehret L., Malek N., Hoffmann I. Plk2 regulates centriole duplication through phosphorylation-mediated degradation of Fbxw7 (human Cdc4). J. Cell Sci. 2012, 125:981-992. 10.1242/jcs.095075.
85. Ji S., Qin Y., Shi S., Liu X., Hu H., Zhou H., et al. ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer. Cell Res. 2015, 10.1038/cr.2015.30.
86. Otto T., Horn S., Brockmann M., Eilers U., Schüttrumpf L., Popov N., et al. Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma. Cancer Cell 2009, 15:67-78. 10.1016/j.ccr.2008.12.005.
87. Popov N., Schülein C., Jaenicke L.A., Eilers M. Ubiquitylation of the amino terminus of Myc by SCF(β-TrCP) antagonizes SCF(Fbw7)-mediated turnover. Nat. Cell Biol. 2010, 12:973-981. 10.1038/ncb2104.
88. Zhang J., Zhu F., Li X., Dong Z., Xu Y., Peng C., et al. Rack1 protects N-terminal phosphorylated c-Jun from Fbw7-mediated degradation. Oncogene 2012, 31:1835-1844. 10.1038/onc.2011.369.
89. Guo Z., Zhou Y., Evers B.M., Wang Q. Rictor regulates FBXW7-dependent c-Myc and cyclin E degradation in colorectal cancer cells. Biochem. Biophys. Res. Commun. 2012, 418:426-432. 10.1016/j.bbrc.2012.01.054.
90. Koo J., Yue P., Deng X., Khuri F.R., Sun S.-Y. mTOR complex 2 stabilizes Mcl-protein by suppressing its glycogen synthase kinase 3-dependent and SCF-FBXW7-mediated degradation. Mol. Cell. Biol. 2015, 35:2344-2355. 10.1128/MCB.01525-14.
91. Wang Z., Liu Y., Zhang P., Zhang W., Wang W., Curr K., et al. FAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7. Oncotarget 2013, 4:2476-2486.
92. Jiang X., Xing H., Kim T.-M., Jung Y., Huang W., Yang H.W., et al. Numb regulates glioma stem cell fate and growth by altering Epidermal growth factor receptor and Skp1-Cullin-F-Box ubiquitin ligase activity. Stem Cells 2012, 30:1313-1326. 10.1002/stem.1120.
93. Tron A.E., Arai T., Duda D.M., Kuwabara H., Olszewski J.L., Fujiwara Y., et al. The glomuvenous malformation protein glomulin binds Rbx1 and regulates Cullin RING ligase-mediated turnover of Fbw7. Mol. Cell 2012, 46:67-78. 10.1016/j.molcel.2012.02.005.
94. Duda D.M., Olszewski J.L., Tron A.E., Hammel M., Lambert L.J., Waddell M.B., et al. Structure of a glomulin-RBX1-CUL1 complex: inhibition of a RING E3 ligase through masking of its E2-binding surface. Mol. Cell 2012, 47:371-382. 10.1016/j.molcel.2012.05.044.
95. Isobe T., Hattori T., Kitagawa K., Uchida C., Kotake Y., Kosugi I., et al. Adenovirus E1A inhibits SCF(Fbw7) ubiquitin ligase. J. Biol. Chem. 2009, 284:27766-27779. 10.1074/jbc.M109.006809.
96. Chen J., Shin J.-H., Zhao R., Phan L., Wang H., Xue Y., et al. CSN6 drives carcinogenesis by positively regulating Myc stability. Nat. Commun. 2014, 5:5384. 10.1038/ncomms6384.
97. Schwickart M., Huang X., Lill J.R., Liu J., Ferrando R., French D.M., et al. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature 2010, 463:103-107. 10.1038/nature08646.
98. Pan J., Deng Q., Jiang C., Wang X., Niu T., Li H., et al. USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer. Oncogene 2015, 34:3957-3967. 10.1038/onc.2014.327.
99. Popov N., Wanzel M., Madiredjo M., Zhang D., Beijersbergen R., Bernards R., et al. The ubiquitin-specific protease USP28 is required for MYC stability. Nat. Cell Biol. 2007, 9:765-774. 10.1038/ncb1601.
100. Sun X.-X., He X., Yin L., Komada M., Sears R.C., Dai M.-S. The nucleolar ubiquitin-specific protease USP36 deubiquitinates and stabilizes c-Myc. Proc. Natl. Acad. Sci. U. S. A. 2015, 112:3734-3739. 10.1073/pnas.1411713112.
101. Diefenbacher M.E., Popov N., Blake S.M., Schülein-Völk C., Nye E., Spencer-Dene B., et al. The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer. J. Clin. Investig. 2014, 124:3407-3418. 10.1172/JCI73733.
102. Diefenbacher M.E., Chakraborty A., Blake S.M., Mitter R., Popov N., Eilers M., et al. Usp28 counteracts Fbw7 in intestinal homeostasis and cancer. Cancer Res. 2015, 75:1181-1186. 10.1158/0008-5472.CAN-14-1726.
103. Schülein-Völk C., Wolf E., Zhu J., Xu W., Taranets L., Hellmann A., et al. Dual regulation of Fbw7 function and oncogenic transformation by Usp28. Cell Rep. 2014, 9:1099-1109. 10.1016/j.celrep.2014.09.057.
104. Li L., Anderson S., Secombe J., Eisenman R.N. The Drosophila ubiquitin-specific protease Puffyeye regulates dMyc-mediated growth. Development 2013, 140:4776-4787. 10.1242/dev.096941.
105. Orlicky S., Tang X., Neduva V., Elowe N., Brown E.D., Sicheri F., et al. An allosteric inhibitor of substrate recognition by the SCF(Cdc4) ubiquitin ligase. Nat. Biotechnol. 2010, 28:733-737. 10.1038/nbt.1646.
106. Selivanova G., Wiman K.G. Reactivation of mutant p53: molecular mechanisms and therapeutic potential. Oncogene 2007, 26:2243-2254. 10.1038/sj.onc.1210295.
107. Rottmann S., Wang Y., Nasoff M., Deveraux Q.L., Quon K.C. A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3beta/FBW7 loss of function. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:15195-15200. 10.1073/pnas.0505114102.
108. Liu L., Ulbrich J., Müller J., Wüstefeld T., Aeberhard L., Kress T.R., et al. Deregulated MYC expression induces dependence upon AMPK-related kinase 5. Nature 2012, 483:608-612. 10.1038/nature10927.
109. Goga A., Yang D., Tward A.D., Morgan D.O., Bishop J.M. Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC. Nat. Med. 2007, 13:820-827. 10.1038/nm1606.
110. Murga M., Campaner S., Lopez-Contreras A.J., Toledo L.I., Soria R., Montaña M.F., et al. Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors. Nat. Struct. Mol. Biol. 2011, 18:1331-1335. 10.1038/nsmb.2189.
111. Chauhan D., Tian Z., Nicholson B., Kumar K.G.S., Zhou B., Carrasco R., et al. A small molecule inhibitor of ubiquitin-specific protease-induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell 2012, 22:345-358. 10.1016/j.ccr.2012.08.007.